Biogen Newsroom

Stifel Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $175

Moomoo NewsDec 16 06:32 ET

Biogen Downgraded to Hold From Buy at Stifel

TipRanksDec 16 06:23 ET

Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $175 From $275

MT NewswiresDec 16 05:43 ET

Biogen Analyst Ratings

BenzingaDec 10 07:55 ET

B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target

BenzingaDec 10 07:39 ET

Biogen Analyst Ratings

BenzingaDec 9 06:42 ET

Jefferies Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $180

Moomoo NewsDec 9 06:31 ET

Biogen's Modest Growth Prospects and Revenue Challenges Highlighted in Hold Rating

TipRanksDec 9 05:40 ET

Biogen Downgraded to Hold From Buy at Jefferies

TipRanksDec 9 05:39 ET

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Biogen (BIIB) and Edwards Lifesciences (EW)

TipRanksDec 5 13:14 ET

Morgan Stanley Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $192

Moomoo NewsDec 5 12:35 ET

RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksNov 27 20:49 ET

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250

Moomoo NewsNov 25 10:30 ET

Jefferies Remains a Buy on Biogen (BIIB)

TipRanksNov 25 10:27 ET

Biogen Analyst Ratings

BenzingaNov 21 08:09 ET

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207

BenzingaNov 21 08:09 ET

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $207

Moomoo NewsNov 21 07:32 ET

Mizuho Securities Adjusts Price Target on Biogen to $207 From $251

MT NewswiresNov 20 10:14 ET

Biogen Price Target Maintained With a $270.00/Share by Needham

Dow JonesNov 18 05:19 ET

Biogen Analyst Ratings

BenzingaNov 18 05:09 ET